Tam Mallorie T, Daboub Alonso, Lou Hayami, Robillard Julie M
Department of Medicine, Division of Neurology, University of British Columbia, Vancouver, BC, Canada.
BC Children's and Women's Hospital, Vancouver, BC, Canada.
J Community Genet. 2024 Feb;15(1):97-101. doi: 10.1007/s12687-023-00677-5. Epub 2023 Oct 3.
This qualitative study explored the motivators and barriers for genetic testing for individuals with aniridia. Semi-structured interviews were conducted with 8 participants. The main findings highlighted the complex and interrelated factors involved in the decision-making process, including family planning, learning about the specific pathogenic variant of the disease and having access to genetic testing. Benefits and potential risks of genetic testing for aniridia were also discussed. For participants, gaining knowledge about their condition was perceived as a benefit, while administrative issues and concerns around privacy were identified as risks. Increased access to quality information about genetic testing and to the service and associated resources are needed to better support people living with aniridia.
这项定性研究探讨了无虹膜症患者进行基因检测的动机和障碍。对8名参与者进行了半结构化访谈。主要研究结果突出了决策过程中涉及的复杂且相互关联的因素,包括计划生育、了解疾病的特定致病变体以及获得基因检测。还讨论了无虹膜症基因检测的益处和潜在风险。对参与者而言,了解自身病情被视为一种益处,而行政问题和对隐私的担忧则被确定为风险。需要增加获取有关基因检测的高质量信息以及服务和相关资源的机会,以更好地支持无虹膜症患者。